ESR1 and prostate carcinoma: Notably, FOXA1, a pioneer factor in development and differentiation [64,65], has been suggested to interact with hormonal receptors (ER and androgen receptor) and play a role in breast cancer and prostate cancer, and even in tamoxifen resistance [66-69].